Skip to content
Primary Menu
About
Management Team
Board of Directors
Scientific Advisors
Pipeline
Publications
NXP800
NXP900
Clinical Trials
Investors
Contact
THE PIPELINE
a. Exclusive worldwide rights acquired from the Institue of Cancer Research, UK
b. Exclusive worldwide rights acquired from the University of Edinburgh